Migraine patients rate new treatment in Real-World study
NCT ID NCT06237062
Summary
This study aimed to understand how satisfied migraine patients were with a treatment called erenumab in real-world settings. Researchers followed 37 adults in the Gulf region who had recently started the treatment, asking them to complete online surveys over 12 weeks. The goal was to measure their satisfaction and see how the treatment affected their migraine days and daily life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIGRAINE are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.